# Sware

> Sware is a Boston-based software company that modernizes GxP validation for life sciences. Its cloud-native Res_Q platform and developer-focused GxPNext product use AI and a decade of regulated validation knowledge to automate the computer system validation (CSV) work that the FDA and other regulators require - helping pharmaceutical, biotech, medical device and CDMO teams cut validation time and cost while staying audit-ready. Formerly Boston Technology Research (BTR), the company rebranded to Sware in 2022 and has raised roughly $26-27M to date.

- **Founded:** 2015
- **Headquarters:** Boston, Massachusetts, United States
- **Founders:** Bryan Ennis (Co-founder (former CEO)), Kosal Keo (Co-founder)
- **Team size:** ~69 employees
- **Products:** Res_Q, GxPNext, Sware GxP Suite
- **Notable:** Rebranded from Boston Technology Research (BTR) to Sware in 2022 with new name and logo, Raised ~$26M total including a $6M Series B in June 2024, Achieved SOC 2 Type II certification (2024) and ISO 9001 certification

## Products & services

- **Res_Q** — Cloud-native, AI-powered GxP validation platform with an open API architecture that lets organizations automate, integrate and scale computer system validation across IT, manufacturing and lab systems in a single system. Covers GCP, GLP, GMP and AI validation and includes the Res_Q Data Cloud built on a decade of validation knowledge.
- **GxPNext** — Agentic validation software integrated directly into software development pipelines, bringing GxP compliance to developers building life sciences applications.
- **Sware GxP Suite** — Unified validation suite spanning five use cases: software validation, AI validation, plant and equipment validation, medical device / SaMD, and GxP for developers.

## Achievements

- Rebranded from Boston Technology Research (BTR) to Sware in 2022 with new name and logo
- Raised ~$26M total including a $6M Series B in June 2024
- Achieved SOC 2 Type II certification (2024) and ISO 9001 certification
- Selected by Salesforce to validate GxP compliance for Life Sciences Cloud (2025)
- Named Box 2025 Life Sciences Partner of the Year
- Launched enhanced AI-powered Res_Q platform and GxPNext for developers (2025)

## Latest updates

- **2025-10** — Launched an enhanced, AI-powered Res_Q platform to advance GxP validation in life sciences.
- **2025-08** — Salesforce and Sware partnership to modernize GxP compliance profiled by industry analysts (Axendia).
- **2025-04** — Selected by Salesforce to validate AI-driven GxP compliance for Salesforce Life Sciences Cloud.
- **2024-09** — Added AI assistance to the Res_Q platform and received SOC 2 Type II certification.
- **2024-06** — Raised $6M Series B led by First Analysis to accelerate life sciences innovation.

## Links

- Website: https://sware.com
- LinkedIn: https://www.linkedin.com/company/sware-by
- Twitter/X: https://twitter.com/Sware_by

---

Profile page: https://yespress.io/sware
Published by YesPress — https://yespress.io
Last updated: 2026-07-17